Inhibition effect of ethanol in naproxen degradation by catalytic ozonation with NiO

Ni-based catalysts used in heterogeneous catalytic ozonation for organic pollutant degradation: a minireview

Among various advanced oxidation processes for wastewater treatment, heterogeneous catalytic ozonation (HCO) has a growing interest in pollutant degradation, e.g., pesticides, pharmaceuticals, cresols, detergents, polymers, dyes, and others. Direct oxidation with ozone can occur by this route or indirectly, generating reactive oxygen species through the catalytic activation of the ozone molecule. Then, many catalytic materials were evaluated, such as unsupported and supported oxides, activated carbon, nanocarbons, carbon nitride, and mesoporous materials. This review focuses on the properties and performance of Ni-based catalysts (NiO, supported NiO, Ni ferrites, and M-Ni bimetallic), emphasizing the reaction mechanisms and the importance of the reactive oxygen species in removing toxic organic compounds.

Enhanced Naproxen Elimination in Water by Catalytic Ozonation Based on NiO Films

This study evaluates naproxen (NP) degradation efficiency by ozonation using nickel oxide films (NiO(F)) as a catalyst. The NiO films were synthesized by chemical vapor deposition and characterized by X-ray diffraction, scanning electron microscopy, atomic force microscopy and X-ray photoelectron spectroscopy. NP degradation was conducted for 5 min using 10 films of NiO(F) comparing against ozonation using 100 mg/L NiO powder in suspension (NiO(S)) and conventional ozonation (O3-conv). Total organic carbon analysis demonstrated a mineralization degree of 12% with O3-conv, 35% with NiO as powder and 22% with NiO(F) after 60 min of reaction. The films of NiO(F) were sequentially used 4 times in ozonation demonstrating the stability of the synthesized material, as well as its properties as a catalyst for ozonation. A proposed modeling strategy using robust parametric identification techniques allows the comparison of NP decomposition pseudo-monomolecular reaction rates.

Improving ozonation to remove carbamazepine through ozone-assisted catalysis using different NiO concentrations

The carbamazepine (CBZ) abatement is herein evaluated using catalytic ozonation at different NiO concentrations as catalyst: 100, 300, and 500 mg L^-1, revealing its total destruction after 5 min of reaction either by conventional or catalytic ozonation. The NiO incorporation in the reactor does not increase the destruction rate, but the catalyst presence enhances the partial mineralization of the contaminant by conversion into oxalic and formic acids and the removal of total organic carbon (TOC) associated with the formation of oxidant species such as hydroxyl radical. Evidence for this behavior is the accumulation rate of the above acids which rise proportionally to the NiO concentration. The highest NiO concentration (500 mg L^-1) reached a maximum TOC removal of 79.2%, which exceeds by 50% the outcome of the conventional treatment. The accumulation-decomposition profiles of oxalic and formic acids suggest the occurrence of simultaneous reaction mechanisms (hydroxyl radicals and complex formations) on the catalyst during CBZ ozonation. According to XPS analysis, the presence of nitrogen species in the NiO-ozonated was attributable to byproducts of CBZ decomposition. The toxicity bioassay based on Lactuca sativa seeds demonstrate that ozonated samples attained similar plant germination than the reference substance (water) after 120 min of treatment. This result is comparable with or without the catalyst presence, indicating the formation of non-toxic accumulated byproducts at the end of the ozonation reaction.

Naproxen in the environment: its occurrence, toxicity to nontarget organisms and biodegradation

This article summarizes the current knowledge about the presence of naproxen in the environment, its toxicity to nontarget organisms and the microbial degradation of this drug. Currently, naproxen has been detected in all types of water, including drinking water and groundwater. The concentrations that have been observed ranged from ng/L to μg/L. These concentrations, although low, may have a negative effect of long-term exposure on nontarget organisms, especially when naproxen is mixed with other drugs. The biological decomposition of naproxen is performed by fungi, algae and bacteria, but the only well-described pathway for its complete degradation is the degradation of naproxen by Bacillus thuringiensis B1(2015b). The key intermediates that appear during the degradation of naproxen by this strain are O-desmethylnaproxen and salicylate. This latter is then cleaved by 1,2-salicylate dioxygenase or is hydroxylated to gentisate or catechol. These intermediates can be cleaved by the appropriate dioxygenases, and the resulting products are incorporated into the central metabolism. KEY POINTS: •High consumption of naproxen is reflected in its presence in the environment. •Prolonged exposure of nontargeted organisms to naproxen can cause adverse effects. •Naproxen biodegradation occurs mainly through desmethylnaproxen as a key intermediate.